Genetic research into bipolar disorder: The need for a research framework that Integrates sophisticated molecular biology and clinically Informed phenotype characterization

Psychiatric Clinics of North America

Volumn 33, Issue 1, 2010, Pages 67-82

  Schulze, Thomas G ^a,b,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Association; Classification; Depression; Linkage; Manic depressive illness; Schizophrenia

Indexed keywords

ANKYRIN; DIACYLGLYCEROL KINASE; LITHIUM; SEROTONIN TRANSPORTER;

BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; EPIGENETICS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENETICS; HUMAN; LINKAGE ANALYSIS; MOLECULAR GENETICS; NEUROBIOLOGY; PHARMACOGENETICS; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

BIPOLAR DISORDER; DEPRESSIVE DISORDER; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LINKAGE (GENETICS); MOLECULAR BIOLOGY; PHENOTYPE; SCHIZOPHRENIA;

EID: 77049125519     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2009.10.005     Document Type: Review

References (128)

1. Baron M. Manic-depression genes and the new millennium: poised for discovery. Mol Psychiatry 2002, 7(4):342-358.
2. Berrettini W.H. Molecular linkage studies of bipolar disorders. Bipolar Disord 2001, 3(6):276-283.
3. Craddock N., Forty L. Genetics of affective (mood) disorders. Eur J Hum Genet 2006, 14(6):660-668.
4. Craddock N., Jones I. Molecular genetics of bipolar disorder. Br J Psychiatry Suppl 2001, 41:s128-s133.
5. Craddock N., Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet 2009, 25(2):99-105.
6. Detera-Wadleigh S.D., McMahon F.J. Genetic association studies in mood disorders: issues and promise. Int Rev Psychiatry 2004, 16(4):301-310.
7. Farmer A., Elkin A., McGuffin P. The genetics of bipolar affective disorder. Curr Opin Psychiatry 2007, 20(1):8-12.
8. Hayden E.P., Nurnberger J.I. Molecular genetics of bipolar disorder. Genes Brain Behav 2006, 5(1):85-95.
9. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 2007, 61(1):3-19.
10. Prathikanti S., McMahon F.J. Genome scans for susceptibility genes in bipolar affective disorder. Ann Med 2001, 33(4):257-262.
11. Schulze T.G., McMahon F.J. Genetic linkage and association studies in bipolar affective disorder: a time for optimism. Am J Med Genet C Semin Med Genet 2003, 123C(1):36-47.
12. Schumacher J., Cichon S., Rietschel M., et al. Nervenarzt 2002, 73(7):581-592. [quiz: 593-4] [in German].
13. Shih R.A., Belmonte P.L., Zandi P.P. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 2004, 16(4):260-283.
14. Sklar P. Linkage analysis in psychiatric disorders: the emerging picture. Annu Rev Genomics Hum Genet 2002, 3:371-413.
15. Taylor L., Faraone S.V., Tsuang M.T. Family, twin, and adoption studies of bipolar disease. Curr Psychiatry Rep 2002, 4(2):130-133.
16. Tsuang M.T., Faraone S.V. The genetics of mood disorders 1990, Johns Hopkins University Press, Baltimore (MD).
17. Luxenburger H. Psychiatrisch-neurologische Zwillingspathologie. Zbl Ges Neurol Psychiat 1930, 56:145-180. [in German].
18. Rosanoff A.J., Handy L.M., Plessett I.R. The etiology of manic-depressive syndromes with special reference to their occurrence in twins. Am J Psychiatry 1934, 91:247-286.
19. Schulze T.G., Fangerau H., Propping P. From degeneration to genetic susceptibility, from eugenics to genethics, from Bezugsziffer to LOD score: the history of psychiatric genetics. Int Rev Psychiatry 2004, 16(4):246-259.
20. Risch N., Botstein D. A manic depressive history. Nat Genet 1996, 12(4):351-353.
21. McQueen M.B., Devlin B., Faraone S.V., et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet 2005, 77(4):582-595.
22. Clerget-Darpoux F., Elston R.C. Are linkage analysis and the collection of family data dead? Prospects for family studies in the age of genome-wide association. Hum Hered 2007, 64(2):91-96.
23. Detera-Wadleigh S.D., McMahon F.J. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 2006, 60(2):106-114.
24. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678.
25. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316(5829):1331-1336.
26. Scott L.J., Mohlke K.L., Bonnycastle L.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316(5829):1341-1345.
27. Sladek R., Rocheleau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445(7130):881-885.
28. Zeggini E., Scott L.J., Saxena R., et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008, 40(5):638-645.
29. Amos C.I., Wu X., Broderick P., et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008, 40(5):616-622.
30. Hung R.J., McKay J.D., Gaborieau V., et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008, 452(7187):633-637.
31. Thorgeirsson T.E., Geller F., Sulem P., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452(7187):638-642.
32. Frayling T.M., Timpson N.J., Weedon M.N., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316(5826):889-894.
33. Loos R.J., Lindgren C.M., Li S., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008, 40(6):768-775.
34. Thorleifsson G., Walters G.B., Gudbjartsson D.F., et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009, 41(1):18-24.
35. Willer C.J., Speliotes E.K., Loos R.J., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009, 41(1):25-34.
36. Helgadottir A., Thorleifsson G., Manolescu A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316(5830):1491-1493.
37. McPherson R., Pertsemlidis A., Kavaslar N., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316(5830):1488-1491.
38. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308(5720):385-389.
39. Maller J., George S., Purcell S., et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006, 38(9):1055-1059.
40. Hampe J., Franke A., Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007, 39(2):207-211.
41. Rioux J.D., Xavier R.J., Taylor K.D., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39(5):596-604.
42. Gudmundsson J., Sulem P., Manolescu A., et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007, 39(5):631-637.
43. Yeager M., Orr N., Hayes R.B., et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007, 39(5):645-649.
44. Lettre G., Jackson A.U., Gieger C., et al. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet 2008, 40(5):584-591.
45. Sanna S., Jackson A.U., Nagaraja R., et al. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet 2008, 40(2):198-203.
46. Weedon M.N., Lango H., Lindgren C.M., et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008, 40(5):575-583.
47. Weedon M.N., Lettre G., Freathy R.M., et al. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Genet 2007, 39(10):1245-1250.
48. Han J., Kraft P., Nan H., et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet 2008, 4(5):e1000074.
49. Sulem P., Gudbjartsson D.F., Stacey S.N., et al. Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet 2008, 40(7):835-837.
50. Sulem P., Gudbjartsson D.F., Stacey S.N., et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 2007, 39(12):1443-1452.
51. Lango H., Weedon M.N. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?. J Intern Med 2008, 263(1):16-27.
52. Baum A.E., Akula N., Cabanero M., et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008, 13(2):197-207.
53. Ferreira M.A., O'Donovan M.C., Meng Y.A., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008, 40(9):1056-1058.
54. Scott L.J., Muglia P., Kong X.Q., et al. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A 2009, 106(18):7501-7506.
55. Sklar P., Smoller J.W., Fan J., et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008, 13(6):558-569.
56. Smith E.N., Bloss C.S., Badner J.A., et al. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 2009, 14(8):755-763.
57. Ollila H.M., Soronen P., Silander K., et al. Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort. Mol Psychiatry 2009, 14(4):351-353.
58. Schulze T.G., Detera-Wadleigh S.D., Akula N., et al. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 2009, 14(5):487-491.
59. Baum A.E., Hamshere M., Green E., et al. Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement. Mol Psychiatry 2008, 13(5):466-467.
60. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373(9678):1891-1904.
61. Narod S.A., Foulkes W.D. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004, 4(9):665-676.
62. Maher B. Personal genomes: the case of the missing heritability. Nature 2008, 456(7218):18-21.
63. Cordell H.J. Genome-wide association studies: detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 2009, [Epub ahead of print].
64. Ioannidis J.P., Thomas G., Daly M.J. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 2009, 10(5):318-329.
65. McCarthy M.I., Abecasis G.R., Cardon L.R., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008, 9(5):356-369.
66. Psychiatric GWAS Consortium Steering Committee A framework for interpreting genome-wide association studies of psychiatric disorders. Mol Psychiatry 2009, 14(1):10-17.
67. Cook E.H., Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455(7215):919-923.
68. Stefansson H., Rujescu D., Cichon S., et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455(7210):232-236.
69. Walsh T., McClellan J.M., McCarthy S.E., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320(5875):539-543.
70. Mefford H.C., Sharp A.J., Baker C., et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008, 359(16):1685-1699.
71. Sebat J., Lakshmi B., Malhotra D., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316(5823):445-449.
72. Weiss L.A., Shen Y., Korn J.M., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008, 358(7):667-675.
73. Zhang D., Cheng L., Qian Y., et al. Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry 2009, 14(4):376-380.
74. Biesecker L., Mullikin J.C., Facio F., et al. The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res 2009, 19(9):1665-1674.
75. Perlis R.H. Pharmacogenetic studies of antidepressant response: how far from the clinic?. Psychiatr Clin North Am 2007, 30(1):125-138.
76. Kirchheiner J., Fuhr U., Brockmoller J. Pharmacogenetics-based therapeutic recommendations-ready for clinical practice?. Nat Rev Drug Discov 2005, 4(8):639-647.
77. Kirchheiner J., Nickchen K., Bauer M., et al. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 2004, 9(5):442-473.
78. Binder E.B., Salyakina D., Lichtner P., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004, 36(12):1319-1325.
79. Hu X.Z., Rush A.J., Charney D., et al. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 2007, 64(7):783-792.
80. Laje G., Paddock S., Manji H., et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry 2007, 164(10):1530-1538.
81. *D) Cohort. Biol Psychiatry 2008, 63(12):1103-1110.
82. McMahon F.J., Buervenich S., Charney D., et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006, 78(5):804-814.
83. *D cohort. Am J Psychiatry 2007, 164(8):1181-1188.
84. *)D study. Neuropsychopharmacology 2008, 33(12):2810-2819.
85. Uher R., Huezo-Diaz P., Perroud N., et al. Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 2009, 9(4):225-233.
86. Grof P., Duffy A., Cavazzoni P., et al. Is response to prophylactic lithium a familial trait?. J Clin Psychiatry 2002, 63(10):942-947.
87. Mamdani F., Groisman I.J., Alda M., et al. Pharmacogenetics and bipolar disorder. Pharmacogenomics J 2004, 4(3):161-170.
88. Perlis R.H., Smoller J.W., Ferreira M.A., et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009, 166(6):718-725.
89. Schulze TG, Alda M, Adli M, et al. The international Consortium on Lithium Genetics (ConLiGen)-an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology, in press.
90. Esteller M. Epigenetics in cancer. N Engl J Med 2008, 358(11):1148-1159.
91. Connor C.M., Akbarian S. DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics 2008, 3(2):55-58.
92. Sharma R.P., Grayson D.R., Gavin D.P. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res 2008, 98(1-3):111-117.
93. Tsankova N., Renthal W., Kumar A., et al. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007, 8(5):355-367.
94. Craddock N., Owen M.J. Rethinking psychosis: The disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry. 2007, 6(2):84-91.
95. Potash J.B. Carving chaos: genetics and the classification of mood and psychotic syndromes. Harv Rev Psychiatry 2006, 14(2):47-63.
96. Rietschel M., Beckmann L., Strohmaier J., et al. G72 and its association with major depression and neuroticism in large population-based groups from Germany. Am J Psychiatry 2008, 165(6):753-762.
97. Schulze T.G., Hedeker D., Zandi P., et al. What is familial about familial bipolar disorder? Resemblance among relatives across a broad spectrum of phenotypic characteristics. Arch Gen Psychiatry 2006, 63(12):1368-1376.
98. Schulze T.G., Ohlraun S., Czerski P.M., et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 2005, 162(11):2101-2108.
99. Wooster R., Neuhausen S.L., Mangion J., et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994, 265(5181):2088-2090.
100. Tekin M., Arnos K.S., Pandya A. Advances in hereditary deafness. Lancet 2001, 358(9287):1082-1090.
101. Evans L., Akiskal H.S., Keck P.E., et al. Familiality of temperament in bipolar disorder: support for a genetic spectrum. J Affect Disord 2005, 85(1-2):153-168.
102. Fisfalen M.E., Schulze T.G., DePaulo J.R., et al. Familial variation in episode frequency in bipolar affective disorder. Am J Psychiatry 2005, 162(7):1266-1272.
103. Jones I., Craddock N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry 2001, 158(6):913-917.
104. Kassem L., Lopez V., Hedeker D., et al. Familiality of polarity at illness onset in bipolar affective disorder. Am J Psychiatry 2006, 163(10):1754-1759.
105. MacKinnon D.F., Zandi P.P., Cooper J., et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry 2002, 159(1):30-35.
106. O'Mahony E., Corvin A., O'Connell R., et al. Sibling pairs with affective disorders: resemblance of demographic and clinical features. Psychol Med 2002, 32(1):55-61.
107. Potash J.B., Toolan J., Steele J., et al. The bipolar disorder phenome database: a resource for genetic studies. Am J Psychiatry 2007, 164(8):1229-1237.
108. Saunders E.H., Scott L.J., McInnis M.G., et al. Familiality and diagnostic patterns of subphenotypes in the National Institutes of Mental Health bipolar sample. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(1):18-26.
109. Schulze T.G., McMahon F.J. Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum Hered 2004, 58(34):131-138.
110. Iannuzzi M.C., Baughman R.P. Reverse phenotyping in sarcoidosis. Am J Respir Crit Care Med 2007, 175(1):4-5.
111. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160(4):636-645.
112. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006, 7(10):818-827.
113. Fangerau H., Ohlraun S., Granath R.O., et al. Computer-assisted phenotype characterization for genetic research in psychiatry. Hum Hered 2004, 58(3-4):122-130.
114. Watt D.C., Katz K., Shepherd M. The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychol Med 1983, 13(3):663-670.
115. Baca-Garcia E., Perez-Rodriguez M.M., Basurte-Villamor I., et al. Diagnostic stability and evolution of bipolar disorder in clinical practice: a prospective cohort study. Acta Psychiatr Scand 2007, 115(6):473-480.
116. Salvatore P., Baldessarini R.J., Tohen M., et al. McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry 2009, 70(4):458-466.
117. Salvatore P., Khalsa H.M., Hennen J., et al. Psychopathology factors in first-episode affective and non-affective psychotic disorders. J Psychiatr Res 2007, 41(9):724-736.
118. Marneros A., Roettig S., Roettig D., et al. The longitudinal polymorphism of bipolar I disorders and its theoretical implications. J Affect Disord 2008, 107(1-3):117-126.
119. Turvey C.L., Coryell W.H., Solomon D.A., et al. Long-term prognosis of bipolar I disorder. Acta Psychiatr Scand 1999, 99(2):110-119.
120. Coryell W., Solomon D., Turvey C., et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003, 60(9):914-920.
121. Goodwin G.M., Anderson I., Arango C., et al. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol 2008, 18(7):535-549.
122. Treuer T., Tohen M. Course and outcome of bipolar disorder-focusing on depressive aspects. Bipolar depression: molecular neurobiology, clinical diagnosis and pharmacotherapy 2009, 29-46. Birkhauser, Basel, Switzerland. C.A. Zarate, H. Manji (Eds.).
123. Regier D.A., Narrow W.E., Kuhl E.A., et al. The conceptual development of DSM-V. Am J Psychiatry 2009, 166:645-650.
124. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008, 9(6):437-452.
125. Newberg A.R., Catapano L.A., Zarate C.A., et al. Neurobiology of bipolar disorder. Expert Rev Neurother 2008, 8(1):93-110.
126. Ross C.A., Margolis R.L., Reading S.A., et al. Neurobiology of schizophrenia. Neuron 2006, 52(1):139-153.
127. Sawamura N., Sawa A. Disrupted-in-schizophrenia-1 (DISC1): a key susceptibility factor for major mental illnesses. Ann N Y Acad Sci 2006, 1086:126-133.
128. Risch N., Herrell R., Lehner T., et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009, 301(23):2462-2471.